Novavax Inc (NASDAQ:NVAX)

8.64
Delayed Data
As of Mar 30
 +0.42 / +5.11%
Today’s Change
3.34
Today|||52-Week Range
9.95
+45.70%
Year-to-Date

Today’s Trading

Previous close8.22
Today’s open8.58
Day’s range8.35 - 8.88
Volume8,085,249
Average volume (3 months)5,882,476
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-19.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book8.55

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+1.39+1.53%
KITEKite Pharma Inc+0.20+0.33%
HALOHalozyme Therapeutic...+0.07+0.50%
OPHTOphthotech Corp-1.09-2.22%
Data as of 3:59pm ET, 03/30/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account